The global testosterone replacement therapy market is expected to grow at a CAGR of -2.42% during the forecast period. Some of the prominent vendors operating in the market include AbbVie, Bayer, Endo Pharmaceuticals, and among others.

Get Free Sample

Vendors provide patient assistance programs to individuals with testosterone deficiency. For instance, AVEED Copay Assistance Program is available for individuals who are insured with commercial plans. The patients with AVEED Copay Assistance Program may pay $0 copay for AVEED. This program covers up to $300 of out-of-pocket costs for each injection of AVEED. Axiron by Eli Lilly is provided with an Axiron saving card. Individuals who are 18 years and above can use the card and are required to pay only $25 per month to buy Axiron.

Similarly, Androderm by Allergan is provided with a digital Androderm Saving Card with which individuals can save up to $50 after the initial spending of $30 on the drug. Therefore, due to the availability of such patient assistance programs, individuals are inclined toward buying these drugs, thereby increasing the growth of the testosterone replacement therapy market.

Browse Full Report - http://bit.ly/2NC00Xa